Vorsitz: T. Christ (Dresden), L. Fabritz (Münster)
| (V516) | Cellular mechanisms of proarrhythmia in a non-failing murine model of Na+/Ca2+ exchanger overexpression |
|
|
C. Pott, M. Ruhe, A. Muszynski, J. S. Schulte, P. Milberg, L. Fabritz, J. I. Goldhaber, K. Philipson, L. Eckardt, G. Breithardt, W. Schmitz, P. Kirchhof, F. U. Müller (Münster; Los Angeles, US) |
| (V517) | Connexin40A96S point mutated mice: a model for human idiopathic atrial fibrillation |
|
|
J. W. Schrickel, R. Andrié, I. Lübkemeier, T. Lewalter, G. Nickenig, L. Lickfett, K. Willecke (Bonn) |
| (V518) | A heterozygous deletion mutation (1493delK) in the cardiac sodium channel leads to a loss-of-function by various mechanisms and to atrioventricular conduction disease. |
|
|
S. Zumhagen, M. W. Veldkamp, C. A. Remme, A. Baartscheer, B. Stallmeyer, M. Paul, E. Schulze-Bahr (Münster; Amsterdam, NL) |
| (V519) | Hyperaldosteronism induces atrial conduction defects and fibrosis thereby stabilizing atrial arrhythmias |
|
|
J.-C. Reil, S.-R. Selejan, B. Münz, A. Buob, C. Mewis, M. Böhm, H.-R. Neuberger (Homburg/Saar) |
| (V520) | Zooming in on a Focus: Simultaneous Endo-Epicardial High Density Mapping of Aconitine-Induced Atrial Fibrillation |
|
|
D. Linz, A. van Hunnik, M. Kuiper, S. Verheule, U. Schotten (Maastricht, NL) |
| (V521) |
Incidence and Origin of ‘Breakthrough’ Events in a 3-Dimensional Substrate for Atrial Fibrillation |
|
|
J. Eckstein, B. Maesen, S. Zeemering, S. Verheule, A. van Hunnik, M. Allessie, U. Schotten (Maastricht, NL) |